GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Novavax, Inc. (NVAX) [hlAlert]

Novavax, Inc. (Novavax) is a clinical-stage biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon preventive options for a range of infectious diseases. These vaccines leverage its virus-like particle (VLP) platform technology coupled with a disposable production technology.
VLPs are genetically engineered three-dimensional nanostructures, which incorporate immunologically important lipids and recombinant proteins. Novavax?s VLPs resemble the virus but lack the genetic material to replicate the virus. Its production technology uses insect cells rather than chicken eggs or mammalian cells. The Company?s product targets include vaccines against the H5N1 and other subtypes of avian influenza with pandemic potential, human seasonal influenza, Varicella Zoster, which causes shingles, and respiratory syncytial virus (RSV). This RSV vaccine was announced on October 30, 2008.
.
( Total: 11 Current Stock Recommendations )
Novavax, Inc.   (11)
Hold 18% Buy 82%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
12/11/2007  
Hold
  
9/1/2009  
Hold
  
9/2/2009  
None
  
11/5/2009  
Buy
  
12/1/2009  
Buy
  
12/3/2009  
Buy
  
3/15/2010  
Buy
  
6/15/2010  
Buy
  
3/15/2011  
Buy
  
9/25/2013  
Buy
  
10/30/2013  
Buy
  
3/11/2014  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy